A civil cause of action for a minor injured by a gender transition procedure.
Impact
If passed, SB405 would create new legal protections for minors and their families under state law, allowing them to seek justice through civil litigation in cases where they believe they have been harmed due to gender transition treatments. This could lead to increased scrutiny on healthcare providers offering these services, as potential liabilities may arise from the procedures. Supporters see this as a necessary step to safeguard vulnerable youth, while critics argue that it could hinder access to essential medical care for those who identify as transgender.
Summary
SB405 introduces a civil cause of action specifically for minors who have been injured as a result of gender transition procedures. The bill recognizes that minors undergoing such medical treatments may face substantial risks and aims to provide a legal avenue for accountability. The underlying intent is to ensure that parents have recourse if their child experiences adverse effects or complications directly linked to these procedures, which has been a significant topic of debate in recent legislative sessions.
Contention
The discussion surrounding SB405 has been contentious, reflecting deep divisions within the state legislature and broader public opinion on issues related to gender identity and medical care for minors. Proponents of the bill argue that it empowers parents and protects children from potentially irreversible medical decisions made at a young age. In contrast, opponents assert that the bill undermines medical autonomy, could instill fear among healthcare providers, and could be used to stigmatize or discriminate against transgender youth seeking necessary healthcare services.
Relating to health benefit plan coverage for and prohibitions on gender transitioning procedures and treatments provided to certain individuals; creating a criminal offense.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.